Skip to main content

Table 2 Clinicopathological data MS patients and control subjects (immunohistochemistochemical study)

From: Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients

Case

Gender

Age

PMD (h)

DD

MS Type

Demyelination (lesion type)

COD

MS

       

11

M

43

8:30

17

SP

yes (active)

Pneumonia

12

F

66

6:00

23

SP

yes (active)

Unknown

13

F

60

10:40

7

PP

yes (active)

Euthanasia

14

M

54

8:15

12

PP

yes (active)

Euthanasia

15

F

50

7:35

17

SP

yes (active)

Euthanasia

16

F

62

6:45

25

Unknown

yes (inactive)

Unknown

17

M

63

7:05

28

SP

yes (inactive)

Cardiac arrest after rupture of abdominal aorta

18

M

47

7:15

7

SP

yes (inactive)

Urosepsis with organ failure

19

M

49

8:00

26

PP

yes (inactive)

Pneumonia by MS

20

M

66

7:30

26

PP

yes (inactive)

Ileus

21

M

61

9:15

31

SP

yes (inactive)

Euthanasia

22

F

57

8:40

27

Unknown

yes (inactive)

Respiratory insufficiency by (uro)sepsis

23

F

77

5:43

6

Unknown

no

Respiratory insufficiency with aspiration pneumonia

24

M

71

7:00

26

PP

no

Pneumonia by aspiration

25

F

76

9:45

20

PP

no

Unknown

26

M

50

9:30

24

PP

no

Unknown

27

M

51

11:00

20

Unknown

no

Unknown

28

M

56

9:50

14

PP

no

Cachexia and exhaustion by end stage MS

Control

       

6

M

84

7:05

   

Exacerbation of COPD

7

M

56

9:15

   

Myocardial infarction

8

F

62

7:55

   

Euthanasia

9

F

92

7:00

   

Acute death, probably pulmonary embolism

10

F

50

4:10

   

Metastasized large cell bronchocarcinoma

11

F

62

7:20

   

Metastases

12

M

82

5:10

   

Pneumonia/cardiovascular accidents

13

M

78

Unknown

   

Cardiac arrest after rupture of abdominal aorta

14

F

84

6:55

   

Myelodysplasia

  1. PMD = Postmortem delay; DD = Disease duration; COD = Cause of death; SP = Secondary progressive; PP = Primary progressive.